What is PBSV's gross margin?

Pharma-Bio (PBSV) has a gross margin of 30% and a net margin of -609%.

What is PBSV's P/E ratio?

Track Pharma-Bio (PBSV) P/E ratio, ROE, and valuation metrics over time.

Where can I see PBSV's full financials?

See Pharma-Bio (PBSV) income statement, cash flow, and balance sheet — quarterly and annual — alongside insider trading activity.

Pharma-Bio (PBSV) Financials — Revenue, Earnings, Cash Flow

$0.50

+0.05 (+11.11%)

Weekly Expected Move ±24.4%

$0 $0 $0 $1 $1

OTC · Industrials · Specialty Business Services · Tech Score Neutral · Power 61 · $11.5M mcap · 8M float · 0.0060% daily turnover · Short 64% of daily vol

Overview Chart Smart Money Financials Income Statement Cash Flow Balance Sheet Earnings

Analysis Technicals Weather Peers ESG Institutions Dark Pool Short Interest Supply Chain

📊 Key Metrics

TTM

$9M

Revenue

-99.5% YoY

$-14M

Net Income

-16461.7% YoY

$-305M

Free Cash Flow

-229.2% YoY

29.6%

Gross Margin

-3.1%

Op. Margin

-608.7%

Net Margin

💰 Income Flow

How revenue becomes profit

💵 Cash Flow

⚠️ Cash Burn Where cash goes

🏦 Balance Sheet

Assets = Liabilities + Equity

📈 Financial Health

Profitability

ROE-0.1%

ROA-0.1%

ROIC-0.0%

Valuation

P/E-1.4

P/B0.0

EV/EBITDA-43.1

Leverage

Debt/Equity0.00

Current Ratio11.30

Interest Cov.0.0x

Quality Scores

Piotroski F4/9

Altman Z2.19

Beneish M800.34